Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
S23 + S4 + GW-501516 Value Pack
1205 in stock
4442 in stock
1677 in stock
1205 in stock
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
This research bundle combines three synthetic compounds frequently studied together in selective receptor and metabolic pathway research: S4 (Andarine), a synthetic research molecule studied for selective molecular pathway interactions; S-23, studied for specific receptor binding properties; and GW-501516 (Cardarine), studied for metabolic pathway modulation. Combined research models allow investigation into how multiple selective receptor compounds and a metabolic modulator may intersect within body composition and metabolic efficiency research. Research applications include comparative selective receptor pathway studies and multi-compound metabolic research design.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Synonyms | S4 + S23 + GW-501516 Value Pack |
|---|---|
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
How do S4 and S-23 differ in their proposed receptor pathway research applications compared to each other?
S4 (Andarine) and S-23 are both studied for selective receptor binding properties but represent structurally distinct compounds within this research category, allowing comparative research into how subtle structural differences influence receptor selectivity and downstream pathway engagement when studied within the same experimental protocol.
What experimental models are used to study this three-compound combination's effects on receptor and metabolic pathways?
Cell-based receptor binding and selectivity assays, alongside metabolic flux measurements (such as glucose uptake and lipid oxidation assays) for the GW-501516 component, are standard methods for studying this combination, typically compared across single-compound and combined-compound treatment arms.
How should researchers structure comparative protocols using this three-compound value pack?
Factorial or staggered experimental designs incorporating single-compound, paired-compound, and full three-compound treatment arms allow researchers to isolate the contribution of each compound and identify any combination-specific effects on selected receptor and metabolic research endpoints.
